Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis

被引:28
|
作者
Cheng, Li [1 ,2 ]
Tan, Botao [3 ]
Yin, Ying [3 ]
Wang, Sanrong [3 ]
Jia, Lang [3 ]
Warner, Gerry [4 ]
Jia, Gongwei [3 ]
Jiang, Wei [3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Resp, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Hlth Management Ctr, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil, 76 Linjiang Rd, Chongqing 400010, Peoples R China
[4] Queen Elizabeth Hosp, Dept Rehabil, Bridgetown, Barbados
关键词
Pulmonary rehabilitation; idiopathic pulmonary fibrosis; exercise capacity; health-related quality of life; RESPIRATORY SOCIETY STATEMENT; QUALITY-OF-LIFE; VALIDATION; BENEFITS;
D O I
10.1177/0269215518779122
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To investigate the short- and long-term effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis (IPF). Data sources: An electronic search of MEDLINE, Embase and Cochrane Central databases along with hand search of relevant papers were performed on 15 March 2018. Review methods: This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature for randomized controlled trials of pulmonary rehabilitation in IPF patients. The outcomes were exercise capacity and health-related quality of life. Two authors independently extracted data, assessed trial eligibility and risk of bias. Meta-analyses were performed using RevMan and STATA software. Results: We extracted data from four randomized controlled trials (142 participants). At short-term follow-up, pulmonary rehabilitation significantly enhanced 6-minute walk distance (6-MWD; weighted mean difference (WMD)=38.38, 95% confidence interval (CI)=4.64-72.12, I-2=60.7%; P<0.05), reduced St. George's Respiratory Questionnaire (SGRQ)/IPF-specific SGRQ (SGRQ-I) total score (WMD=-8.40, 95% CI=-11.44 to -5.36, I-2=0%; P<0.00001). At long-term follow-up, pulmonary rehabilitation could not enhance 6-MWD (WMD=17.02, 95% CI=-26.87 to 60.81, I-2=36.3%; P=0.43) or reduce SGRQ/SGRQ-I total score (WMD=-3.45, 95% CI=-8.55 to 1.64, I-2=38.3%; P=0.088). Conclusion: In patients with IPF, pulmonary rehabilitation showed short-term effects in enhancing exercise capacity and health-related quality of life, while it had no detectable effects at long-term follow-up.
引用
收藏
页码:1299 / 1307
页数:9
相关论文
共 50 条
  • [1] Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Aravena, Carlos
    Labarca, Gonzalo
    Venegas, Carmen
    Arenas, Alex
    Rada, Gabriel
    PLOS ONE, 2015, 10 (08):
  • [2] Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Pitre, Tyler
    Khalid, Muhammad Faran
    Cui, Sonya
    Zhang, Melanie C.
    Husnudinov, Renata
    Mah, Jasmine
    Helmczi, Wryan
    Su, Johnny
    Guy, Brent
    Scallan, Ciaran
    Jones, Aaron
    Zeraatkar, Dena
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 73
  • [3] Statins and Cognition: A Systematic Review and Meta-analysis of Short- and Long-term Cognitive Effects
    Swiger, Kristopher J.
    Manalac, Raoul J.
    Blumenthal, Roger S.
    Blaha, Michael J.
    Martin, Seth S.
    MAYO CLINIC PROCEEDINGS, 2013, 88 (11) : 1213 - 1221
  • [4] Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gomes-Neto, Mansueto
    Silva, Cassio Magalhaes
    Ezequiel, Diego
    Conceicao, Cristiano Sena
    Saquetto, Micheli
    Machado, Adelmir Souza
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2018, 38 (05) : 273 - 278
  • [5] The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
    Chenchen Zang
    Yan Zheng
    Yanqing Wang
    Lisha Li
    European Journal of Medical Research, 26
  • [6] The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
    Zang, Chenchen
    Zheng, Yan
    Wang, Yanqing
    Li, Lisha
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)
  • [7] EFFICACY OF ANTIOXIDANT IN IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Kandhare, Amit D.
    Mukherjee, Anwesha
    Ghosh, Pinaki
    Bodhankar, Subhash L.
    EXCLI JOURNAL, 2016, 15 : 636 - 651
  • [8] Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review
    Le Bai
    Li Zhang
    Tingyu Pan
    Wei Wang
    Dian Wang
    Cassidy Turner
    Xianmei Zhou
    Hailang He
    Respiratory Research, 22
  • [9] Idiopathic Pulmonary Fibrosis and Lung Cancer A Systematic Review and Meta-analysis
    Brown, Stacey-Ann Whittaker
    Dobelle, Molly
    Padilla, Maria
    Agovino, Mariangela
    Wisnivesky, Juan P.
    Hashim, Dana
    Boffetta, Paolo
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (08) : 1041 - 1051
  • [10] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Zheng, Qiang
    Cox, Ingrid A.
    Campbell, Julie A.
    Xia, Qing
    Otahal, Petr
    de Graaff, Barbara
    Corte, Tamera J.
    Teoh, Alan K. Y.
    Walters, E. Haydn
    Palmer, Andrew J.
    ERJ OPEN RESEARCH, 2022, 8 (01)